Clinical Study

Variability in Uremic Control during Continuous Venovenous Hemodiafiltration in Trauma Patients

Table 2

Individual data: Trauma patients with acute kidney injury with continuous renal replacement therapy (CRRT) grouped with and without rhabdomyolysis ( ).

Patient numberRhabdomyolysisCRRT daysMedian daily CRRT durationMedian ΔureaMedian Δcreatinine

1No521,1−0,05−0,05
2No519,7 0,10 0,22
3No522,3 0,15 0,15
4No522,3 0,12 0,17
5Yes516,8 0,03 0,14
6Yes520,8 0,01 0,01
7No318,7−0,10 0,16
8Yes522,8 0,03 0,04
9No518,7 0,11 0,28
10No521,8−0,08 0,02
11Yes519,2 0,23 0,25
12No416,1−0,01 0,13
13Yes19,1
14No523,8−0,14 0,01
15Yes416,1 0,17 0,18
16No59,8−0,23−0,12
17Yes510,3−0,18−0,02
18No521,4 0,08 0,03
19Yes418,5−0,14−0,18
20Yes415,8−0,02 0,21
21Yes124,0
22No215,6−0,06 0,05
23Yes516,3−0,20−0,24
24No523,5 0,17 0,25
25Yes518,5−0,10−0,05
26No411,5−0,08−0,15
27Yes216,1 0,03 0,08
28No514,4−0,09−0,03
29No519,4 0,04 0,01
30No414,6−0,07 0,18
31Yes513,0−0,30−0,32
32Yes124,0
33No519,9 0,18 0,12
34Yes311,8−0,35 0,05
35No520,9−0,07 0,12
36Yes38,6−0,19−0,17

Δurea = (Ureaday N−Ureaday N + 1)/Ureaday N where Ureaday N is the serum concentration of urea at day N, and Urea day N + 1 is the serum concentration of urea at day N+1.
Δcreatinine = (Creatinineday N−Creatinineday N + 1)/Creatinineday N where Creatinineday N is the serum concentration of creatinine at day N, and Creatinineday N + 1 is the serum concentration of creatinine at day N+1.